 | -$0.65 Earnings Per Share Expected for Tcr2 Therapeutics Inc (NASDAQ:TCRR) This Quarter
www.americanbankingnews.com - February 21 at 11:46 AM |
| Tcr2 Therapeutics (NASDAQ:TCRR) and Repligen (NASDAQ:RGEN) Financial Analysis
www.americanbankingnews.com - February 19 at 10:37 PM |
 | TCR² Therapeutics to Participate in Two Upcoming Conferences in February
finance.yahoo.com - February 18 at 7:14 AM |
| Tcr2 Therapeutics Inc (NASDAQ:TCRR) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 13 at 3:58 AM |
| Head-To-Head Review: BioCryst Pharmaceuticals (NASDAQ:BCRX) vs. Tcr2 Therapeutics (NASDAQ:TCRR)
www.americanbankingnews.com - February 7 at 12:06 AM |
| TCR² Therapeutics to Present an Allogeneic Construct at the Keystone Symposia Conference on Emerging Cellular Therapies: Cancer and Beyond
finance.yahoo.com - February 3 at 9:22 AM |
| Tcr2 Therapeutics Inc (NASDAQ:TCRR) Expected to Announce Earnings of -$0.65 Per Share
www.americanbankingnews.com - January 29 at 9:42 PM |
| Need To Know: TCR2 Therapeutics Inc. (NASDAQ:TCRR) Insiders Have Been Buying Shares
finance.yahoo.com - January 21 at 6:06 PM |
 | Tcr2 Therapeutics (TCRR) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 17 at 5:55 PM |
 | TCR(2) Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
www.marketwatch.com - January 7 at 5:00 PM |
| TCR² Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 7:06 AM |
| TCR² Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 12 at 11:54 AM |
 | TCRR TCR2 Therapeutics Inc. Common Stock
www.nasdaq.com - October 24 at 7:14 AM |
| TCR2 Therapeutics (NASDAQ:TCRR) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - October 23 at 2:18 PM |
| Tcr² Therapeutics Appoints Industry Veteran Angela Justice, Ph.D., as Chief People Officer
finance.yahoo.com - October 9 at 7:46 AM |
| TCR² Therapeutics to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - September 27 at 1:05 PM |
| TCR2 Therapeutics Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - September 3 at 12:40 PM |
| TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference
finance.yahoo.com - August 30 at 11:52 AM |
| How Much Of TCR2 Therapeutics Inc. (NASDAQ:TCRR) Do Institutions Own?
finance.yahoo.com - August 22 at 3:46 PM |
| TCR2 Therapeutics Inc. (TCRR) Shares March Higher, Can It Continue?
finance.yahoo.com - August 22 at 11:35 AM |
| TCR2 Therapeutics EPS beats by $0.03
seekingalpha.com - August 8 at 12:50 PM |
| TCR² Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 12:50 PM |
| TCR² Therapeutics to Participate in Upcoming Conferences in August
finance.yahoo.com - August 6 at 8:38 PM |
| TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires
finance.yahoo.com - August 6 at 12:41 PM |
| TCR2 Therapeutics teams up with NCI in cancer study of proprietary T cells; shares up 3%
seekingalpha.com - July 31 at 1:44 PM |
| TCR2 Therapeutics Announces Partnership with the National Cancer Institute for Phase 1/2 Trial of TC-210
finance.yahoo.com - July 31 at 1:44 PM |
| TCR2 Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
finance.yahoo.com - June 28 at 9:25 AM |
| Who Has Been Buying TCR2 Therapeutics Inc. (NASDAQ:TCRR) Shares?
finance.yahoo.com - May 24 at 3:26 PM |
| TCR2 Therapeutics Inc. (TCRR) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 15 at 5:58 AM |
| TCR2 Therapeutics' (TCRR) CEO Garry Menzel on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 13 at 8:26 PM |
| TCR2 Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 13 at 8:26 PM |
| TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity of the Company’s Novel TRuC™-T Cells
finance.yahoo.com - May 7 at 7:45 AM |
| TCR2 Therapeutics Announces First Quarter 2019 Earnings Conference Call and Webcast
finance.yahoo.com - April 30 at 7:32 AM |
| TCR2 Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - April 1 at 3:19 PM |
| TCR2 Therapeutics Presents Preclinical Data on its Lead Solid Tumor and Blood Cancer Programs at the American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - March 28 at 3:22 PM |
| TCR2 collaborates with CGT Catapult to manufacture T cell therapies for cancer
seekingalpha.com - March 26 at 3:20 PM |
| TCR2 Therapeutics Announces Collaboration With Cell and Gene Therapy Catapult for the Manufacturing of its Novel T Cell Therapies for Cancer
finance.yahoo.com - March 26 at 3:20 PM |
 | TCR2 Therapeutics Inc.
www.barrons.com - March 4 at 3:15 PM |
| TCR2 Therapeutics Announces Exercise of Over-Allotment Option
finance.yahoo.com - February 27 at 5:17 AM |
| IPO Outlook For The Week: Biotechs And Another Virgin Group Addition
finance.yahoo.com - February 26 at 3:15 PM |
| TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock
finance.yahoo.com - February 26 at 3:15 PM |
